Beovu
Beovu (brolucizumab) is an injection into the back space of the eye to help treat wet age-related macular degeneration (wet AMD). This medication is given to you by your healthcare provider once a month for 3 months, then you'll only need it once every 2 to 3 months.
What is Beovu (brolucizumab)?
What is Beovu (brolucizumab) used for?
Treatment of wet age-related macular degeneration (wet AMD)
How Beovu (brolucizumab) works
With wet AMD, abnormal blood vessels grow in the eye and leak fluid into the back of the eye (the macula). Vascular endothelial growth factor (VEGF) is a protein that plays a role in making these new blood vessels.
Beovu (brolucizumab) is a VEGF inhibitor. This means it blocks VEGF, which helps slow the growth of abnormal blood vessels.
Drug Facts
What are the side effects of Beovu (brolucizumab)?
Common Side Effects
- Blurry vision (10%)
- Cataract (7%)
- Red patch on the eye (6%)
- Eye floaters (5%)
- Eye pain (5%)
Other Side Effects
- Eye inflammation
- Greater pressure in the eye
- Abnormal bleeding in the eye
- Watery eyes
- Feeling like something is in your eye
- Itchiness, rash, or redness around injection area
Serious Side Effects
- Retinal detachment: flashing lights, shadow or dark curtain across your field of vision, vision loss
- Unusual changes in your vision
Source: DailyMed
The following side effects have also been reported
Side effects that you should report to your care team as soon as possible:
- Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
- Blurry vision, vision loss, seeing wavy or bent objects or blind spots with dark, light, or flashing spots
- Heart attack—pain or tightness in the chest, shoulders, arms, or jaw, nausea, shortness of breath, cold or clammy skin, feeling faint or lightheaded
- New or worsening eye pain, redness, irritation, or discharge
- Stroke—sudden numbness or weakness of the face, arm, or leg, trouble speaking, confusion, trouble walking, loss of balance or coordination, dizziness, severe headache, change in vision
- Sudden eye pain or change in vision such as blurry vision, seeing halos around lights, vision loss
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
- Blurry vision
- Eye pain
- Increased tears after use
Pros and cons of Beovu (brolucizumab)
Pros
Only need to get eye injection once every 2 to 3 months (after a few starter doses); less often than the Eylea (afilbercept) alternative
Can help improve visual sharpness (e.g., gain 7 letters on an eye chart at your eye specialist's office)
Shown in studies to be safe and work well for people older than age 65
Cons
Must get as an injection in your eye
Causes more eye inflammation (swelling) than the Eylea (afilbercept) alternative
Risk of serious eye-related issues
Pharmacist tips for Beovu (brolucizumab)
Ask your eye specialist about the best ways to check your vision at least once a week. This way, you can let your provider know right away if you notice any vision changes during treatment with Beovu (brolucizumab).
Be sure to stay on track with the treatment plan your provider creates for you. Wet AMD is a long-term condition, so you'll need to receive Beovu (brolucizumab) regularly to manage your symptoms.
Research suggests that certain lifestyle changes can help delay the worsening of your vision due to wet AMD. These lifestyle changes include eating a vitamin- and mineral-rich diet (such as green, leafy vegetables), staying active, and avoiding smoking.
Frequently asked questions about Beovu (brolucizumab)
How to save using GoodRx
What are the risks and warnings for Beovu (brolucizumab)?
Beovu (brolucizumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Severe eye inflammation and separation of the retina from the back of the eye (retinal detachment)
Beovu (brolucizumab) can cause severe eye inflammation and retinal detachment. Retinal detachment is a condition where your retina (tissue in the back of your eye that senses light and helps you see) pulls away from its normal place in your eye. When this happens, you can experience flashing lights, changes in your vision, or vision loss. Let your provider know if you have eye pain (a sign of eye inflammation), trouble seeing, or anything that seems unusual about your vision.
Issues with your eye(s)
Risk factors: Inflammation inside the eye
There is a risk for eye problems with Beovu (brolucizumab), even just after your first dose. Problems can include retinal vasculitis (swollen vessels of the retina), retinal vascular occlusion (blockage of the small veins that carry blood away from the retina), or greater pressure inside your eye. Remember to go to your follow-up appointments so your provider can examine your eye and make sure there are no serious issues.
Greater risk of a clot
Generally, VEGF inhibitors like Beovu (brolucizumab) have the potential risk of clotting events (e.g., stroke, heart attack, death) when injected in the eye. In clinical studies, 4.5% of people receiving Beovu (brolucizumab) experienced a clotting event. Get medical help right away if you experience signs of a clot (e.g., shortness of breath, fast breathing, chest pain), stroke (e.g., sudden weakness, loss of balance, trouble speaking), or heart attack (e.g., chest or arm pain).
Beovu (brolucizumab) dosage forms
Typical dosing for Beovu (brolucizumab)
Beovu (brolucizumab) is usually given by your eye specialist (ophthalmologist) either in their office or another healthcare setting.
In general, you'll get a 6 mg dose injected into the back of your eye once every month for the first 3 months. Then, you'll only need a 6 mg dose once every 2 to 3 months.
Beovu (brolucizumab) contraindications
Infections in or around the eyeball
Eye inflammation or swelling
What are alternatives to Beovu (brolucizumab)?
Neovascular (wet) age-related macular degeneration (AMD)
Macular edema following retinal vein occlusion (RVO)
Myopic choroidal neovascularization (mCNV)
Diabetic macular edema (DME)
Diabetic retinopathy (DR)
Get savings updates for Beovu (brolucizumab)
Receive price alerts, news, and other messages from GoodRx about Beovu (brolucizumab) and other healthcare topics and relevant savings offers.By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Browse medications
View AllResearch prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.